Literature DB >> 2971687

Cutaneous manifestations of early human immunodeficiency virus exposure.

R S Berger1, M F Stoner, E R Hobbs, T J Hayes, R N Boswell.   

Abstract

After demonstrating antibodies to the human immunodeficiency virus (HIV), two hundred patients were interviewed and given a complete cutaneous and mucous membrane examination. By means of the Walter Reed Staging Classification System for HIV infection, 155 patients were classified as having Walter Reed stage 1A-2A (WR1A-WR2A) infection. The prevalence of seborrheic dermatitis in this group was 36%. There were no other significant cutaneous findings in the WR1A-WR2A patient population.

Entities:  

Mesh:

Year:  1988        PMID: 2971687     DOI: 10.1016/s0190-9622(88)70175-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Topographical and physiological differences of the skin mycobiome in health and disease.

Authors:  Jay-Hyun Jo; Elizabeth A Kennedy; Heidi H Kong
Journal:  Virulence       Date:  2016-10-18       Impact factor: 5.882

2.  Genotyping by RAPD-PCR analyses of Malassezia furfur strains from pityriasis versicolor and seborrhoeic dermatitis patients.

Authors:  Rinaldo F Gandra; Rita C G Simão; Flávia E Matsumoto; Bosco C M da Silva; Luciana S Ruiz; Eriques G da Silva; Walderez Gambale; Claudete R Paula
Journal:  Mycopathologia       Date:  2006-10       Impact factor: 2.574

Review 3.  Seborrhoeic dermatitis.

Authors:  Juan Jorge Manríquez; Pablo Uribe
Journal:  BMJ Clin Evid       Date:  2007-07-01

4.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

Review 5.  The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials.

Authors:  Odeh Alsmeirat; Som Lakhani; Musab Egaimi; Osama Idris; Mohamed Elkhalifa
Journal:  Cureus       Date:  2022-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.